Bt Group Plc (BT) 27.46 $BT BT Group Shares Down 24.4%

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Bt Group Plc (BT) 27.46 $BT

BT Group Shares Down 24.4% Since SmarTrend's Sell Call (BT)
Comtex SmarTrend(R) - Thu Jul 28, 1:09AM CDT
SmarTrend identified a Downtrend for BT Group (NYSE:BT) on December 8th, 2015 at $35.41. In approximately 8 months, BT Group has returned 24.43% as of today's recent price of $26.76.
BT: 27.46 (+0.25)

Brexit Wins, But at what Cost to British Firms?
Zacks Equity Research - Zacks Investment Research - Fri Jun 24, 11:13AM CDT
Britain's decision to leave the EU has dropped a bombshell on two of its major sectors, finance and technology.
BCS: 8.02 (+0.18), JPM: 64.56 (+0.91), BT: 27.46 (+0.25), HSBC: 33.66 (+1.50), MS: 28.40 (+0.40)

SmarTrend Watching for Potential Pullback in Shares of BT Group After 1.53% Gain
Comtex SmarTrend(R) - Wed Jun 22, 3:56PM CDT
BT Group (NYSE:BT) traded in a range yesterday that spanned from a low of $31.80 to a high of $32.20. Yesterday, the shares gained 1.5%, which took the trading range above the 3-day high of $31.77 on volume of 235,000 shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.
BT: 27.46 (+0.25)

Zacks.com featured highlights: Carnival, BT Group, BHP Billiton and National Grid
Zacks Equity Research - Zacks Investment Research - Wed Jun 22, 8:30AM CDT
Zacks.com featured highlights: Carnival, BT Group, BHP Billiton and National Grid
CUK: 47.20 (+0.18), BT: 27.46 (+0.25), NGG: 71.67 (-1.05), BBL: 25.56 (+0.26)

Buy These 4 Stocks that Shot Up as Brexit Fears Diminished
Zacks Equity Research - Zacks Investment Research - Tue Jun 21, 9:14AM CDT
Invest in these four top-notch British firms as polls showed a swing to "remain" in the run-up to the Brexit vote.
CUK: 47.20 (+0.18), BT: 27.46 (+0.25), NGG: 71.67 (-1.05), BBL: 25.56 (+0.26)

New Strong Buy Stocks for June 21st
Swarup Gupta - Zacks Investment Research - Tue Jun 21, 7:11AM CDT
New Strong Buy Stocks for June 21st
FNSR: 18.69 (+0.62), BMO: 63.08 (-0.03), COMM: 28.79 (+0.13), BT: 27.46 (+0.25), LPX: 20.02 (-0.06)

5 British Stocks to Watch as Brexit Vote Looms
Swarup Gupta - Zacks Investment Research - Tue Jun 14, 10:25AM CDT
Industry and market watchers are split over the pros and cons of such a move.
BTI: 125.37 (-2.91), RYAAY: 69.88 (+0.64), BT: 27.46 (+0.25), HSBC: 33.66 (+1.50), BP: 32.82 (-0.63), UL: 45.87 (-1.13), VOD: 31.14 (+0.36)

Level 3 Communications to Shut Down Legacy Voice Service
Zacks Equity Research - Zacks Investment Research - Wed Jun 08, 8:56AM CDT
Level 3 Communications Inc. (LVLT) has sought permission from the FCC to discontinue its legacy voice services based on outdated TDM technology.
LVLT: 49.05 (+0.23), S: 6.07 (+0.11), BT: 27.46 (+0.25), VZ: 53.85 (-0.15), ORAN: 15.19 (-0.04)

Global Unified Communications as a Service (UCaaS) Industry
PR Newswire - Thu May 26, 3:54PM CDT
This report analyzes the worldwide markets for Unified Communications as a Service (UCaaS) in US$ Million. The Global, U.S. & European markets are independently analyzed by the following Segments: Collaboration Application, Telephony, UC Application, and Contact Center. The report provides separate comprehensive analytics for the US, Canada, Japan, Europe, Asia-Pacific, Latin America, and Rest of World. Annual estimates and forecasts are provided for the period 2015 through 2022. Market data and analytics are derived from primary and secondary research. Company profiles are primarily based on public domain information including company URLs. The report profiles 117 companies including many key and niche players such as -
T: 43.06 (-0.10), BT: 27.46 (+0.25), EGHT: 13.46 (-0.12)

Global Managed Security Service Industry
PR Newswire - Thu May 26, 2:05PM CDT
This report analyzes the worldwide markets for Managed Security Services in US$ Million by the following End-Use Sectors: Financial, Government, Healthcare, Manufacturing, Utilities, and Others. The Global market is also analyzed by the following Delivery Model Type and Service Segments: Cloud-Based Security Services (Content Security, DDoS Mitigation, IDS/IDP, Firewalls, & Other Cloud-Based Security Services), and CPE-Based Security Services (Content Security, DDoS Mitigation, IDS/IDP, Firewalls, and Other CPE-Based Security Services). The report provides separate comprehensive analytics for the US, Canada, Japan, Europe, Asia-Pacific, Latin America, and Rest of World. Annual estimates and forecasts are provided for the period 2015 through 2022. Also, a six-year historic analysis is provided for these markets. Market data and analytics are derived from primary and secondary research. Company profiles are primarily based on public domain information including company URLs. The report profiles 114 companies including many key and niche players such as -
T: 43.06 (-0.10), BT: 27.46 (+0.25)

Global Unified Communications as a Service (UCaaS) Strategic Business Report 2016-2022 - Analysis, Technologies & Forecasts - Key Vendors: 8x8, AT&T, BT Group - Research and Markets
BusinessWire - Tue May 24, 4:12AM CDT
Research and Markets has announced the addition of the "Unified Communications as a Service (UCaaS) - Global Strategic Business Report" report to their offering.
BT: 27.46 (+0.25)

eGain to Host Digital+AI Day 2016 in Chicago
Marketwired - Thu May 19, 5:30AM CDT
Event Will Feature Thought Leadership, Cutting-Edge Innovation and Proven Best Practices to Accelerate Digital Transformation in Customer Engagement
BT: 27.46 (+0.25), EGAN: 2.55 (+0.02)

Telefonica's O2 and Hutchison Deal Fails to Cross EU Hurdle
Zacks Equity Research - Zacks Investment Research - Thu May 12, 8:18AM CDT
The proposed merger between Telefonica SA (TEF)-controlled O2 and Hutchison Whampoa, which is currently operating under the 3 UK brand, has been vetoed by the EC on anti-competitive grounds.
LBTYA: 31.98 (+0.55), BT: 27.46 (+0.25), TEF: 9.43 (-0.03), VOD: 31.14 (+0.36)

Is Liberty Global Mulling the Takeover of Telefonica's O2?
Zacks Equity Research - Zacks Investment Research - Wed May 11, 7:51AM CDT
As per recent reports, U.K. cable TV behemoth Liberty Global plc (LBTYA) may consider taking over Spanish telecom behemoth Telefonica SA (TEF)-controlled O2.
LBTYA: 31.98 (+0.55), BT: 27.46 (+0.25), TEF: 9.43 (-0.03), VOD: 31.14 (+0.36)

Upgrade Alert for BT Group (BT)
Comtex SmarTrend(R) - Fri Apr 29, 3:32AM CDT
BT Group (NYSE:BT) was upgraded from Sell to Neutral at UBS today. The stock closed yesterday at $32.08 on volume of 263,000 shares, above average daily volume of 239,000. There is potential upside of 186.5% for shares of BT Group based on a current price of $32.08 and an average consensus analyst price target of $91.91. BT Group shares should first meet resistance at the 50-day moving average (MA) of $32.51 and find additional resistance at the 200-day MA of $51.80.
BT: 27.46 (+0.25)

BT Statement Regarding FCC Business Data Services Vote
PR Newswire - Thu Apr 28, 10:48AM CDT
Today, the Federal Communications Commission took a major step forward in its commitment to bring real reform to the critical market for business data services. For over a decade, American consumers, businesses, and the US economy have paid the price for the enduring lack of competition in this market. The FCC is now poised to usher in a new competitive and sustainable business data services framework to the benefit of the entire broadband economy. We thank the FCC for its action today and look forward to continuing our work together to ensure that competition governs this critical input to innovation.
BT: 27.46 (+0.25)

Downgrade Alert for BT Group (BT)
Comtex SmarTrend(R) - Thu Apr 21, 3:58AM CDT
BT Group (NYSE:BT) was downgraded from Buy to Hold at Jefferies today. The stock closed yesterday at $31.88 on volume of 402,000 shares, above average daily volume of 245,000. BT Group has overhead space with shares priced $31.88, or 65.3% below the average consensus analyst price target of $91.91. BT Group shares should first meet resistance at the 50-day moving average (MA) of $32.67 and find additional resistance at the 200-day MA of $52.94.
BT: 27.46 (+0.25)

Is Telefonica's O2 and 3UK Merger on the Verge of Collapse?
Zacks Equity Research - Zacks Investment Research - Wed Apr 20, 10:45AM CDT
The proposed merger deal between U.K. wireless giant Hutchison Whampoa, which is currently operating under the 3UK brand and Spanish telecom behemoth Telefonica SA (TEF) controlled O2 is likely to be vetoed by the European Union Competition Commission (EC).
BT: 27.46 (+0.25), TEF: 9.43 (-0.03), VOD: 31.14 (+0.36), ORAN: 15.19 (-0.04)

Telefonica's O2 & Hutchison Merger Faces Roadblock in UK
Zacks Equity Research - Zacks Investment Research - Fri Apr 15, 2:45PM CDT
The proposed merger deal between U.K. wireless giant Hutchison Whampoa, which is currently operating under the 3 UK brand and Spanish telecom behemoth Telefonica SA (TEF) controlled O2 is again facing serious regulatory threat.
BT: 27.46 (+0.25), TEF: 9.43 (-0.03), VOD: 31.14 (+0.36), ORAN: 15.19 (-0.04)

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Evotec’s $2.9M Grant Advances Drug Safety Tech

Updated Category News Views 87

Revitalizing Drug Development with Human Stem Cells Evotec's latest win—a crisp $2.9 million grant from the Gates Foundation—is like a shot of adrenaline for drug safety innovation. This isn't just another drop in the bucket; it's a solid boost toward improving how we screen potential drugs for fetal risks before they're tossed into the costly whirlpool of clinical...

Continue Reading
Investors Gear Up for Lennar Class Action Lawsuit

Updated Category News Views 399

High Stakes and Hard Hits for Lennar Stockholders There’s rarely a dull moment in the world of Wall Street, and Lennar Corporation (NYSE: LEN) is proving that rule right now. As a whiff of scandal wafts through the air, the famed homebuilder and its bigwigs are staring down the barrel of a formidable class action lawsuit. The question is, just how deep do the alleged...

Continue Reading
Ambrosia Biosciences Unveils Promising Nonclinical Metabolic Data

Updated Category News Views 448

Ambrosia's Latest Nonclinical Revelations Ambrosia Biosciences has just thrown out some major bait at ObesityWeek® 2026. The highlight? New nonclinical data profiles for two of their understudy small molecule programs—AMB-895 and AMB-131. It may sound niche, but in this sector, promising data spins heads. Their GLP-1 receptor agonist, AMB-895, and GIP receptor...

Continue Reading
Segway Powersports Dominates Baja 1000 with Class 2 Sweep

Updated Category News Views 72

Catching the eye of any betting man, Segway Powersports has turned its maiden outing at the relentless SCORE Baja 1000 into a rousing victory. Their arrival on this unforgiving stage with a one-two in Class 2 isn't just a lucky roll—you don't chance upon podium sweeps in such gritty contests. Dissecting the Drive: Commitment and Coordination Unfolding across Baja's...

Continue Reading
Pollo AI Unveils York AI: Automating Social Growth

Updated Category News Views 0

York AI Debuts as the New Kid on the Block Amid the hustle and bustle of a tech-savvy Singapore, Pollo AI’s latest offering, York AI, sashays onto the scene with the promise of putting social media growth on cruise control. We're talking about a digital sidekick that seems to know your online persona better than you do. It’s tailored for everyone from the small-time...

Continue Reading
Ascletis' Preclinical Successes: Future of Obesity Treatment

Updated Category News Views 14

Pharma Giants Eyeing a New Potential Well, it seems the world of pharma is buzzing with Ascletis’ latest developments in the obesity treatment arena. They’ve just showcased some intriguing preclinical data at ObesityWeek® 2026. The standout? A cocktail of advancements that might just put a dent in the obesity epidemic if further studies pan out. ASC30_48: A Daily...

Continue Reading
IDEAYA's IDE101: A New Front in Cancer Battle

Updated Category News Views 412

IDEAYA's Bold Move in Precision Medicine IDEAYA Biosciences, no stranger to the frontlines of cancer treatment, is gunning for a breakthrough with their latest pick, IDE101. They're jumping into the ring with a potential first-in-class inhibitor targeting CDKN2A-deficiency—a notorious player in the solid tumor game. They're not just mixing things up for the sake of it;...

Continue Reading
Fapon's MEDICA 2026 Bid: Game-Changer or Same Old?

Updated Category News Views 89

Fapon's Ambitious Pitch at MEDICA: A Real Deal? MEDICA 2026 sees Fapon stepping up, laden with flashy promises and hardened expertise. Set up in Düsseldorf, these folks are pushing their Local Manufacturing Solutions harder than a door-to-door vacuum seller. The main pitch? Bolstering local IVD production with their comprehensive tech transfer services. How many outfits...

Continue Reading
Local Voices to Shape Mekong's Story in New Alliance

Updated Category News Views 284

Unpacking the New Storytelling Strategy Right off the bat, let's make it clear—this isn't just another run-of-the-mill environmental project announcement. When the National Geographic Society teams up with ThaiBev to empower Southeast Asian storytellers, they're not just waving around the usual conservation banner. Instead, they're betting on local voices to lead the...

Continue Reading
Akeso's Gumokimab Wins NMPA Approval for AS Treatment

Updated Category News Views 115

Gumokimab Approved: A New Dawn in AS Treatment Yeah, the biotech world shifts gears today as Akeso's gumokimab received the green light from China's National Medical Products Administration (NMPA). This approval for treating ankylosing spondylitis, or AS, isn't just another checkbox for Akeso; it's a game-changer in tackling this chronic inflammatory disease. Why should...

Continue Reading

Top 5 Most Recently Viewed Articles

O-I Glass Announces Participation in Citi’s 2025 Conference

Updated Category News Views 208

O-I Glass Participation in the 2025 Basic Materials Conference PERRYSBURG, Ohio — O-I Glass, Inc., known for its commitment to creating exceptional glass products, is set to participate in the upcoming Citi’s 2025 Basic Materials Conference. This significant event will take place on a Wednesday in December, and features notable presentations from O-I's leadership....

Continue Reading
Osmium Partners Proposes Strategic Plan for Articore Growth

Updated Category News Views 104

Osmium Partners Proposes a Four-Step Plan for Articore Osmium Partners has recently made headlines with their proposal for Articore, aiming to elevate shareholder value through a methodical four-step approach. This initiative is driven by Osmium's belief that Articore's current management strategy lacks direction and has resulted in missed opportunities for growth and...

Continue Reading
Amplify Energy Set to Shine at EnerCom Denver Conference 2025

Updated Category News Views 135

Amplify Energy’s Participation in EnerCom Denver Conference Amplify Energy Corp. is gearing up to participate in the renowned annual EnerCom Denver Conference in 2025. This event, known for bringing together leading experts and investors in the energy sector, offers Amplify a prime platform to showcase its strategic initiatives and growth potential. Focus on Investor...

Continue Reading
Safe Life Expands CPR Training and AED Services through Acquisition

Updated Category News Views 197

Safe Life Strengthens National Coverage for Life-Saving Training Safe Life has made a significant move by acquiring HeartCert, a company known for its specialization in automated external defibrillators (AEDs) and CPR training. This acquisition allows Safe Life to broaden its reach into the Midwest, enhancing its commitment to providing life-saving training and equipment...

Continue Reading
Express Scripts Challenges FTC's Drug Pricing Conclusions

Updated Category News Views 106

Express Scripts Files Lawsuit Against the FTC Express Scripts, a major player in the pharmacy benefit manager sector, has recently taken legal action against the U.S. Federal Trade Commission (FTC). This lawsuit stems from a report that criticizes the role of pharmacy benefit managers in the pricing of medications. Express Scripts contends that the report's conclusions...

Continue Reading